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Abstract: Mast cells participate in allergies and infl  ammation by secreting a variety of pro-infl  ammatory mediators. Curcumin, 
the active component of turmeric, is a polyphenolic phytochemical with anti-tumor, anti-infl  ammatory, anti-oxidative, and 
anti-allergic properties. The effects of curcumin on compound 48/80-induced mast cell activation and passive cutaneous 
anaphylactoid reactions are unknown. In this report, we investigated the influences of curcumin on the passive cutaneous 
anaphylactoid response in vivo and compound 48/80-induced mast cell activation in vitro. The mechanism of action was 
examined by calcium uptake measurements and cAMP assays in mast cells. Curcumin signifi  cantly attenuated the mast cell-
mediated passive cutaneous anaphylactoid reaction in an animal model. In agreement with this in vivo activity, curcumin 
suppressed compound 48/80-induced rat peritoneal mast cell (RPMC) degranulation and histamine release from RPMCs. 
Moreover, compound 48/80-elicited calcium uptake into RPMCs was reduced in a dose-dependent manner by curcumin. 
Furthermore, curcumin increased the level of intracellular cAMP and significantly inhibited the compound 48/80-induced 
reduction of cAMP in RPMCs. Th   ese results corroborate the fi  nding that curcumin may have anti-allergic activity.
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potent vasoactive mediator implicated in the acute phase of 
immediate hypersensitivity (Petersen et al.,1996). Various 
acute and chronic allergic responses are caused by these 
mediators. Mast cell degranulation can also be elicited by the 
basic secretagogues. The most potent secretagogues include 
the synthetic compound 48/80 and polymers of basic amino 
acids (Ennis et al.,1980). Compared with the natural process, 
a high concentration of compound 48/80 induces an almost 
90% release of histamine from mast cells. Th   us, an appropriate 
amount of compound 48/80 has been used as a direct and 
convenient reagent to investigate the mechanisms of allergy 
and anaphylaxis (Allansmith et al.,1989). The murine mast 
cell is a good experimental model for the study of compound 
48/80-induced histamine release.
Curcumin is a yellow dye in the crude drug “Turmeric” 
(Curcumae Rhizoma) from the rhizome of Curcuma longa 
L. (Zingiberaceae). Curcumin is known to have anti-tumor, 
anti-inflammatory, anti-oxidative, and anti-allergic effects 
Introduction
   
Mast cells are the primary effector cells involved in an 
allergic or immediate hypersensitivity response. Activation 
of mast cells occurs in response to a challenge by a specific 
antigen against which the surface immunoglobulin E (IgE) 
is directed, or by other IgE-directed ligands. Activated mast 
cells can produce histamine, as well as a wide variety of other 
infl  ammatory mediators such as eicosanoids, proteoglycans, 
proteases and several pro-inflammatory and chemotactic 
cytokines such as tumor necrosis factor-α, interleukin (IL)-
6, IL-4, IL-8, and IL-13 (Kalesnikoff   & Galli, 2008). Among 
them, histamine remains the best-characterized and most Eff  ects of curcumin on compound 48/80-induced mast cell 
activation
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(Cui et al., 2006; Eybl et al., 2006; Kurup & Barrios, 2008). 
In addition, previous studies demonstrated that curcumin 
had an inhibitory eff  ect on histamine release from mast cells 
triggered by IgE, calcium ionophore A23187, or concanavalin 
A (Suzuki et al., 2005; Lee et al., 2008). However, there are no 
reports to date concerning the suppressive eff  ect of curcumin 
on compound 48/80-induced anaphylactoid response. 
In this study, we evaluated the effect of curcumin on the 
passive cutaneous anaphylactoid response and compound 
48/80-induced histamine release from mast cells. In addition, 
the amount of calcium uptake and intracellular cAMP was 
determined to clarify the mechanism by which curcumin 
inhibited histamine release from mast cells.
     
Materials and Methods
Materials  
Curcumin, compound 48/80, disodium cromoglycate 
(DSCG), bovine serum albumin (BSA), and HEPES were 
purchased from Sigma Chemical Co. (St. Louis, MO, USA). 
Percoll solution was purchased from Pharmacia (Uppsala, 
Sweden). For all in vitro experiments, curcumin was dissolved 
in dimethylsulfoxide (DMSO) and freshly diluted in HEPES-
Tyrode buffer (136 mM NaCl, 5 mM KCl, 2 mM CaCl2, 11 
mM NaHCO3, 0.6 mM NaH2PO4, 2.75 mM MgCl2, 5.4 mM 
HEPES, 1.0 mg/mL BSA, 1.0 mg/mL glucose, 0.1 mg/mL 
heparin, pH 7.4) before use. 
Experimental animals  
Male Sprague-Dawley rats (8 weeks old, 230~280 g) were 
purchased from Damool Science (Daejeon, Korea). Animals 
were housed 3~5 per cages in laminar air-flow cabinets 
maintained at 22±1
oC and a relative humidity of 55±10% 
throughout the study. The Animal Research Committee of 
Chonbuk National University approved the animal study in 
accordance with the guidelines of the National Institutes of 
Health (NIH publication #85-23, 1985).
   
Passive cutaneous anaphylactoid response in rats 
Curcumin (10, 50, 100 mg/kg body weight) was orally 
administered to each rat 1 hour before the injection of 
compound 48/80, which was injected intradermally (0.25 
μg/50 μL) into the dorsal skin. Evans blue solution (1%) was 
intravenously injected into the penile vein of each rat and 30 
minutes after the injection, the rats were sacrificed. Tissue 
sections around the intradermal injection site were excised 
and weighed, followed by extraction of extravasated Evans 
blue dye by incubation of biopsies in 1 mL formamide at 55
oC 
for 24 hours. Absorbance was measured at 620 nm with a 
spectrophotometer (Spectra MAX PLUS, Molecular Devices, 
CA, USA), and tissue Evans blue concentrations quantifi  ed by 
interpolation on a standard curve of dye concentrations in the 
range of 0.01 to 30 μg/mL.
   
Preparation of rat peritoneal mast cells (RPMCs)  
RPMCs were isolated as previously described (Cochrane 
& Douglas, 1974). In brief, rats were anesthetized with ether, 
injected with 10 mL of calcium-free HEPES-Tyrode buffer 
into the peritoneal cavity, and the abdomen gently massaged 
for approximately 90 seconds. The peritoneal cavity was 
opened, and the fluid aspirated using a Pasteur pipette. 
RPMCs were purified using a Percoll density gradient as 
described in detail elsewhere (Hachisuka et al.,1988). RPMC 
preparation was approximately 95% pure as assessed by 
toluidine blue staining and at least 98% of these cells were 
viable as assessed by trypan blue exclusion. Purifi  ed RPMCs 
(1×10
6 cells/mL) were resuspended in HEPES-Tyrode buff  er.
   
RPMC viability assay  
To test the viability of RPMCs, the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric 
assay was performed as previously described (Yoshimura 
et al., 2004). Briefly, RPMCs (2×10
5 cells/well) were 
incubated with various concentrations (10~100 μM) of 
curcumin at 37
oC for 2 hours. After addition of MTT (100 
μg in 100 μL saline), RPMCs were incubated at 37
oC for 1 
hour. Crystallized MTT was dissolved and the absorbance 
measured at 570 nm with a spectrophotometer (Spectra MAX 
PLUS, Molecular Devices, CA, USA). 
   
Histamine assay  
RPMC suspensions (2×10
5 cells in 200 μL) were pre-
incubated with curcumin (10~50 μM) at 37
oC for 5 minutes 
and then incubated with compound 48/80 (0.25 μg/mL) 
for 15 minutes. Following centrifugation at 150×g for 10 
minutes at 4
oC, the amount of histamine in the supernatant 
was determined by the radioenzymatic method (Harvima 
et al., 1988). The inhibition percentage of histamine release 
was calculated using the following formula: % inhibition= 
[(histamine release without curcumin-histamine release with 
curcumin) /histamine release without curcumin]×100. Anat Cell Biol 43:36~43, 2010 Yun-Ho Choi, et al 38
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Measurement of 
45Ca uptake  
Th   e calcium uptake of mast cells was measured according 
to the method described by Choi et al. (Choi et al., 2006a). 
Purifi  ed RPMCs were resuspended in HEPES-Tyrode buff  er 
containing 
45Ca (1.5 mCi/mL; 1 Ci=3.7×10
10 becquerels; 
PerkinElmer Life Sciences, MA, USA), and incubated at 4
oC 
for 10 minutes. Mast cell suspensions were preincubated 
with curcumin (10~50 μM) at 37
oC for 5 minutes and then 
incubated with compound 48/80 (0.25 μg/mL) at 37
oC for 15 
minutes. Th   e reaction was stopped by the addition of 1 mM 
lanthanum chloride. The samples were centrifuged 3 times 
at 150×g for 10 minutes at 4
oC, and then RPMCs were lysed 
with 10% Triton X-100 and vigorous shaken. Radioactivity of 
the solution was measured in a scintillation β-counter (Liquid 
Scintillation Analyzer, A Canberra Company, Australia).
   
cAMP assay  
The cyclic adenosine-3’, 5’ monophosphate (cAMP) level 
was measured by the method described by Holmegaard 
(Holmegaard, 1982). In brief, an RPMC suspension was 
added to an equivalent volume (200 μL) of prewarmed buff  er 
containing the drug in an Eppendorf tube. Th   e reaction was 
allowed to proceed for discrete time intervals, terminated by 
centrifugation at 150×g for 10 minutes at 4
oC, and then each 
sample was added to 250 μL of 50 mM sodium acetate buff  er 
(pH 6.2) under vigorous vortexing, followed by snap freezing 
in liquid nitrogen. Frozen samples were thawed and vortexed 
and the debris sedimented by centrifugation at 1,200×g for 
10 minutes at 4
oC. The cAMP level in the supernatant was 
determined by radioimmunoassay using a Rianen assay 
system (PerkinElmer Life Sciences, Boston, MA, USA).
   
Statistical analysis  
Th   e results obtained were expressed as mean±SEM for the 
number of experiments. Statistical evaluation of the results 
was performed using one-way ANOVA, followed by Duncan’s 
multiple range tests. Results with P<0.05 were considered 
statistically signifi  cant.
Results
Curcumin attenuates the passive cutaneous 
anaphylactoid response 
To confi  rm the anti-anaphylactoid eff  ect of curcumin, we 
used an in vivo model induced by compound 48/80. It has 
been previously demonstrated that the intradermal injection 
of compound 48/80 into the dorsal skin of rats provokes 
an increase of mast cell-dependent vascular permeability 
documented by Evans blue extravasation (Choi et al., 2006b). 
As shown in Table 1, oral administration of curcumin dose-
dependently reduced the vascular permeability changes 
triggered by compound 48/80. Likewise, DSCG (a reference 
drug) exhibited a signifi  cant inhibition at a dose of 100 mg/
kg.
Table 1.  Inhibitory effect of curcumin on compound 48/80-induced 
passive cutaneous anaphylactoid response
Treatment
(mg/kg BW)
Compound 48/80 
(0.25 μg/site)
Amount of evans 
blue (μg/g)
Inhibition
(%)*
Curcumin 0 - 47.25±3.8 -
0 +   261.59±14.32 -
10 +   238.13±11.90 08.96
†
50 +   164.56±12.74 37.09
†
100 +   142.81±06.49 45.41
†
DSCG 100 +   127.35±08.67 51.32
†
Curcumin or DSCG was orally administrated at 1 hour before compound 
48/80 injection. Twenty micro liters of compound 48/80 (0.25 μg/site) were 
intradermally injected into the shaved flank of Sprague-Dawley rats. Each 
amount of Evans blue represents the mean±S.E.M. of five independent 
experiments. *Inhibition (%) = [(amount of Evans blue without curcumin - 
amount of Evans blue with curcumin)/amount of Evans blue without 
curcumin]×100. 
†P<0.05, signifi  cantly diff  erent from the control value. 
Fig. 1. Eff  ect of curcumin on rat peritoneal mast cell (RPMC) viability. 
RPMCs were treated with the various concentrations of curcumin 
for 2 hours. RPMC viability was determined by MTT assay and the 
percentage of viability was calculated as a ratio of A570 of control cells 
(treated with HEPES-Tyrode buffered solution). Each data value 
represents the mean±S.E.M. of fi  ve independent experiments.Eff  ects of curcumin on compound 48/80-induced mast cell 
activation
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Curcumin has no cytotoxicity on RPMCs at a dose of 
10~50 μM
MTT conversion assay was used to determine the viability 
of RPMCs exposed to curcumin. Viable cells were almost 
100% aft  er exposure to 10~50 μM of curcumin for 2 hours. 
However, at 100 μM, curcumin had cytotoxic effects on 
RPMCs (Fig. 1). Th   us, we performed in vitro experiments at 
10~50 μM of curcumin.
   
Curcumin inhibits compound 48/80-induced RPMC 
degranulation
To investigate how curcumin inhibited the passive 
cutaneous anaphylactoid response, we evaluated the eff  ect of 
curcumin on compound 48/80-induced RPMC degranulation 
(Fig. 2). Normal RPMCs were generally oval in shape and 
contained many fine granules surrounding a prominent 
nucleus (Fig. 2A). After stimulation with compound 
48/80 for 5 minutes, RPMCs were degranulated (Fig. 2B). 
Characteristics of mast cell degranulation were cell swelling, 
cytoplasmic vacuoles, and extruded granules near the cell 
surface. When RPMCs were incubated with curcumin 
alone, RPMCs were similar to those seen in (Fig. 2A, C) 
Pretreatment with curcumin inhibited the degranulation 
of RPMCs stimulated with compound 48/80, and cell sizes 
appeared to be somewhat larger than the control (Fig. 
2D). The results suggest that curcumin inhibits compound 
48/80-induced mast cell degranulation.
   
Curcumin inhibits compound 48/80-induced 
histamine release from RPMCs  
To investigate how curcumin inhibited the passive 
cutaneous anaphylactoid response, we also evaluated the 
effect of curcumin on compound 48/80-induced mast 
cell activation. The effect of curcumin on compound 
48/80-induced histamine release from RPMCs is shown in 
Fig. 3. The histamine release from compound 48/80-treated 
RPMCs was reduced in a dose-dependent manner by 
curcumin (58 and 80% inhibition at 25 and 50 μM, 
respectively). 
   
Curcumin reduces compound 48/80-induced calcium 
uptake into RPMCs 
It is well established that an increase in calcium uptake of 
RPMCs contributes to the release of  histamine (Akagi et al., 
1994). Treatment with curcumin alone showed no change 
in calcium uptake. However, calcium uptake was greatly 
increased by stimulation of RPMCs with compound 48/80. 
Th   e compound 48/80-induced calcium uptake was inhibited 
in a concentration-dependent manner by curcumin (Fig. 4). 
Fig. 2. Inverted light micrographs of rat 
peritoneal mast cell (RPMC, arrows). 
(A) The normal RPMC in HEPES-
Tyrode buffered solution. (B) The 
Degranulated RPMC aft  er the addition 
of compound 48/80. (C) The RPMCs 
observed within 10 minutes after the 
addition of curcumin (50 μM) show 
similar fi  ndings as seen in Fig. 2A. (D) 
The RPMCs pretreated with curcumin   
observed within 10 minutes after the 
addition of compound 48/80, show 
similar findings as seen in Fig. 2C. 
Bars=10 μm.Anat Cell Biol 43:36~43, 2010 Yun-Ho Choi, et al 40
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Curcumin increases intracellular cAMP level in 
RPMCs  
The cAMP pathway is believed to be critical for the 
regulation of mast cell activation. An increase of cAMP is 
known to precede the inhibition of histamine release from 
mast cells activated by compound 48/80 (Kaliner & Austen, 
1974). To investigate the mechanism of curcumin on the 
reduction of histamine release from RPMCs stimulated by 
compound 48/80, we assessed intracellular cAMP levels. 
Treatment of curcumin alone increased cAMP levels in 
a dose-dependent manner. Treatment of RPMCs with 
compound 48/80 showed a significant decrease in cAMP 
levels as compared to those treated with buffer alone 
(49.05±3.75% of normal value). However, pretreatment with 
curcumin blocked the compound 48/80-induced reduction of 
cAMP in RPMCs (Fig. 5). 
Discussion
As part of our studies on bioactive constituents from 
natural medicines, we previously reported various inhibitors 
against mast cell degranulation and histamine release induced 
by compound 48/80 (Choi et al., 2006a; 2006b). In this study, 
curcumin inhibited compound 48/80-induced systemic 
anaphylaxis and anti-DNP IgE-mediated PCA. Th  ese  results 
indicate that nonspecific and specific mast cell-dependent 
allergic reactions were signifi  cantly inhibited by curcumin. It 
is well-recognized that compound 48/80 can induce a mast 
cell-dependent, non-specific anaphylactoid reaction. The 
mechanism of anaphylactoid response triggered by compound 
48/80 is considered to be due to the massive release of 
vasoactive amines, such as histamine, from mast cells and 
Fig. 4. Eff  ect of curcumin on compound 48/80-induced calcium uptake 
into rat peritoneal mast cell (RPMC). RPMCs were preincubated 
with curcumin at 37
oC for 5 minutes prior to the incubation with 
compound 48/80. Curcumin dose-dependently inhibited compound 
48/80-induced calcium uptake into RPMCs. Each data value 
represents the mean±S.E.M. of fi  ve independent experiments. *P<0.05, 
significantly different from the control value. C48/80: compound 
48/80.
Fig. 3. Effect of curcumin on compound 48/80-induced histamine 
release from rat peritoneal mast cell (RPMC). RPMCs were 
preincubated with curcumin at 37
oC for 5 minutes prior to the 
incubation with compound 48/80. Curcumin dose-dependently 
inhibited compound 48/80-induced histamine release. Each data 
value represents the mean±S.E.M. of five independent experiments. 
*P<0.001, significantly different from the control value. C48/80: 
compound 48/80. 
Fig. 5. Effect of curcumin on the compound 48/80-induced 
decrease of cAMP level in rat peritoneal mast cell (RPMC). Various 
concentrations of curcumin were added into the RPMCs suspension 
for 5 minutes, and cAMP levels were measured. Curcumin inhibited 
the compound 48/80-induced cAMP reduction of RPMCs in a dose-
dependent manner. Each data value represents the mean±S.E.M. of 
five independent experiments. *P<0.05 and 
†P<0.001, significantly 
diff  erent from the normal value; 
‡P<0.001, signifi  cantly diff  erent from 
the control value. C48/80: compound 48/80.Eff  ects of curcumin on compound 48/80-induced mast cell 
activation
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basophils (Allansmith et al., 1989). As noted, histamine is a 
typical mediator that causes various pathophysiologic events 
in acute allergic reactions (Galli, 1993). Th   us, it is postulated 
that curcumin inhibits mast cell-mediated anaphylactoid 
responses by suppressing histamine release from RPMCs.   
Compound 48/80 is known to activate mast cell secretory 
processes by increasing the rate of GTPγS binding to 
G-proteins (Palomäki & Laitinen, 2006); in turn, the activation 
of G-proteins can trigger intracellular signaling events such as 
activation of phospholipase, protein kinase C (PKC) and Ca
2+ 
signaling which ultimately results in the release of histamine 
from these cells. Inositol 1,4,5-triphosphate then causes 
the movement of Ca
2+ form the endoplasmic reticulum, 
triggering store-operated Ca
2+ entry through specialized Ca
2+ 
release-activated calcium channels (Turner & Kinet, 1999). 
Degranulation of mast cells is involved in the synergistic 
activation of PKC and the increase in intracellular calcium 
concentration. Th   e increase in intracellular Ca
2+ induces the 
movement of granules to the plasma membrane followed by 
the degranulation of mast cells or basophils and activated 
formation of infl  ammatory mediators such as prostaglandins 
and leukotrienes. Compound 48/80 also stimulates histamine 
release from RPMCs in both the presence and absence of 
extracellular calcium. The present study demonstrates that 
curcumin potently suppressed histamine release probably 
through the inhibition of the degranulation process following 
a rise in intracellular Ca
2+ levels, in accordance with previous 
reports (Matsuda et al., 2004; Suzuki et al., 2005; Nugroho et 
al., 2009).
The cAMP pathway is supposed to be critical to the 
activation of mast cells. It has been reported that agents that 
induce the elevation of intracellular cAMP levels can attenuate 
the stimulated release of mediators from mast cells (Weston 
& Peachell, 1998). Moreover, several studies have shown an 
algorithm between cAMP and calcium uptake in RPMCs. 
In general, increased cAMP inhibits superoxide anion 
generation via cAMP-dependent protein phosphorylation 
in RPMCs stimulated by compound 48/80 (Fukuishi et 
al., 1997). Decreased superoxide anion, as well as cAMP, 
impedes inositol 1,4,5-triphosphate or GTP-induced calcium 
release from the endoplasmic reticulum (Yoshii et al., 1988; 
Akagi et al., 1994). Accordingly, calcium-filling state in the 
endoplasmic reticulum blocks a calcium infl  ux into RPMCs, 
which leads to a reduction in the  free intracellular calcium 
content (Hoth & Penner, 1993). Consequently, decreased 
intracellular calcium prevents histamine release from RPMCs 
(Yoshii et al., 1988; Akagi et al., 1994).  Interestingly, treatment 
with curcumin signifi  cantly increases the cAMP level beyond 
the basal level. Although the mechanism of curcumin-
induced cAMP production has not been elucidated, curcumin 
may activate adenylate cyclase directly or indirectly, otherwise 
inhibiting cAMP phosphodiesterase. In addition, curcumin 
prevents compound 48/80-induced cAMP reduction and 
calcium uptake of RPMCs in a dose-dependent fashion. 
According to these observations, the inhibitory mechanism of 
curcumin on histamine release from compound 48/80-treated 
RPMCs may be due to an increase of intracellular cAMP. 
Based upon this information, we speculate that the curcumin-
induced increase in cAMP inhibits calcium uptake into 
RPMCs via the cascade of intracellular events described 
previously and the subsequent decrease of intracellular 
calcium content hinders histamine release from RPMCs. 
In summary, the present data demonstrate that curcumin 
suppresses both the passive cutaneous anaphylactoid 
response and compound 48/80-induced mast cell activation. 
This is the first study to evaluate the effect of curcumin on 
the anaphylactoid reaction induced by compound 48/80. 
Although there are a few diff  erences among the experimental 
conditions in studies concerning anti-allergic activities of 
curcumin, our results confi  rm those of Suzuki and co-workers 
and Lee and co-workers (Suzuki et al., 2005; Lee et al., 2008). 
It is well known that reactive species (ROS) are intimately 
relevant to the induction of infl  ammation. Th   e ROS generated 
in macrophages may produce prostaglandins, nitric oxide, 
and cytokines, leading to the development of inflammation 
(Haddad et al., 2001). Curcumin was reported to depress 
the release of ROS from macrophages (Joe & Lokesh, 1994), 
inhibit the release of histamine from RPMCs (Suzuki et al., 
2005), and the release of TNF-α, and IL-4 from RBL-2H3 
cells (Matsuda et al., 2004; Lee et al., 2008). These findings 
indicate that curcumin is closely associated with anti-allergic 
activities (Kurup & Barrios, 2008). Th   e anti-allergic and anti-
oxi  dative activities of curcumin and related compounds, such 
as glycosides and bis-demethoxy analogs, have currently been 
investigated by Suzuki et al. (Suzuki et al., 2005). Th  eir  results 
suggest that most of the compounds develop anti-allergic 
activities through mechanisms related to both anti-oxidative 
and non anti-oxidation activities. In conclusions, curcumin 
may have benefi  cial eff  ects in the prevention or treatment of 
mast cell-mediated allergic diseases. Th   e detailed mechanisms 
of action of curcumin need to be studied further.Anat Cell Biol 43:36~43, 2010 Yun-Ho Choi, et al 42
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